Mirabegron (brand name Myrbetriq) is a prescription medication that belongs to the class of β₃‑adrenergic receptor agonists. It’s primarily used to treat overactive bladder (OAB) symptoms such as urinary urgency, frequency, and urge incontinence.
1. How It Works
- Mechanism of Action
Mirabegron activates β₃‑adrenergic receptors in the bladder’s detrusor muscle. This stimulates cyclic‑AMP production, leading to relaxation of the bladder’s detrusor muscle during the storage phase. The net result is increased bladder capacity and a reduction in urgency and incontinence episodes.
2. Approved Uses
- Overactive Bladder (OAB) in adults (both men and women) who have urgency, frequency, and/or urge incontinence.
- Used when anticholinergic medications are ineffective, poorly tolerated, or contraindicated.
- Sometimes prescribed off‑label for urinary retention associated with neurogenic bladder, though evidence is limited.
3. Dosage & Administration
| Form |
Typical Starting Dose |
Titration |
Max Daily Dose |
Administration |
| 50 mg tablets |
50 mg once daily (usually in the morning) |
Increase by 25 mg if needed after at least 1 week |
100 mg once daily |
Oral, with or without food |
| 100 mg tablets |
50 mg once daily |
See above |
100 mg once daily |
Oral, with or without food |
- Start low, go slow: Many patients begin at 25 mg (if available as an extended‑release formulation) or 50 mg, especially if they have renal impairment or are on other drugs affecting blood pressure.
- Take at the same time each day to maintain steady levels.
- If you miss a dose: take it as soon as you remember unless it’s close to the next dose; then skip it. Do not double up.
4. Common Side Effects
| Symptom |
Frequency (approx.) |
Management Tips |
| Increased blood pressure |
5–10 % |
Check BP regularly; consider a home monitor |
| Headache |
10–20 % |
Hydration, over‑the‑counter analgesics (acetaminophen) |
| Nasal congestion |
5–10 % |
Decongestants (use with caution) |
| Urinary tract infection (UTI) |
1–3 % |
Prompt treatment of UTIs; maintain good hygiene |
| Dry mouth (rare) |
<1 % |
Sip water, sugar‑free gum |
| Dizziness |
<1 % |
Avoid driving until you know how it affects you |
Serious but rare: allergic reactions (rash, itching, swelling, difficulty breathing), severe hypertension, or heart rhythm changes. Seek emergency care if these occur.
5. Contraindications & Precautions
- Uncontrolled hypertension: Mirabegron can raise blood pressure. Tight BP control is required before initiating therapy.
- Severe renal impairment (CrCl < 30 mL/min): Dose adjustment or avoidance in extreme cases.
- Severe hepatic impairment: Limited data; use cautiously.
- Pregnancy & lactation: No well‑established safety data. Use only if benefits outweigh risks, and discuss with your clinician.
- Patients with heart block (III‑degree) or those on drugs that prolong the QT interval: Potential for arrhythmias.
- Concurrent use with strong CYP2D6 inhibitors or inducers: May alter mirabegron levels.
6. Drug‑Drug Interactions
| Drug Class |
Effect on Mirabegron |
What to Watch For |
| Strong CYP2D6 inhibitors (e.g., fluoxetine, paroxetine) |
↑ Mirabegron concentration |
↑ blood pressure, dizziness |
| Strong CYP2D6 inducers (e.g., rifampin, carbamazepine) |
↓ Mirabegron concentration |
Reduced efficacy |
| Beta‑blockers |
May blunt the blood‑pressure effect |
Monitor BP; consider dose adjustment of beta‑blocker |
| ACE inhibitors / ARBs |
Possible additive BP‑lowering effect |
Monitor BP closely |
| Anticholinergic agents |
Additive anticholinergic burden (dry mouth, constipation) |
Use with caution |
| Other BP‑lowering drugs |
Synergistic BP reduction |
Monitor BP; avoid extreme hypotension |
If you’re on multiple medications, let your pharmacist or prescriber know—they can review interactions and adjust therapy accordingly.
7. What to Expect
- Onset of action: Most patients start noticing improvement in urgency and frequency within 2–4 weeks, but full benefit may take 12 weeks.
- Efficacy: In clinical trials, mirabegron reduced urge‑incontinence episodes by about 60 % versus placebo.
- Long‑term use: Studies up to 2 years have shown sustained benefit with a similar safety profile.
8. Lifestyle & Self‑Care Tips
- Bladder diary: Track voiding frequency, urgency, and incontinence episodes to monitor progress.
- Fluid management: Stay hydrated, but avoid excessive caffeine or alcohol—both can irritate the bladder.
- Timed voiding: Practice scheduled voiding to reduce urgency.
- Pelvic floor exercises (Kegels): Strengthen pelvic muscles; often recommended alongside medication.
- Regular BP checks: Especially in the first few weeks after starting mirabegron.
9. When to Call Your Doctor
- Severe hypertension (systolic > 180 mmHg or diastolic > 110 mmHg) that doesn’t improve with lifestyle measures.
- Persistent dizziness or fainting.
- Signs of an allergic reaction (rash, itching, swelling, shortness of breath).
- Unresolved or worsening urinary symptoms after 4–6 weeks of therapy.
10. Storage & Disposal
- Storage: Keep at room temperature (15–30 °C/59–86 °F), away from moisture and heat.
- Disposal: Do not flush medications down the toilet or drain unless instructed. Use a local drug take‑back program or follow your pharmacy’s guidelines for safe disposal.
Bottom Line
Mirabegron (Myrbetriq) is an effective, β₃‑adrenergic agonist for overactive bladder that relaxes the bladder muscle and reduces urgency and incontinence. It is generally well tolerated but can elevate blood pressure and interact with other drugs. Regular monitoring of blood pressure, awareness of potential side effects, and communication with your healthcare provider are key to a safe and successful treatment.
Disclaimer: This information is for educational purposes only and does not replace professional medical advice. Always consult your prescribing clinician or pharmacist before starting, stopping, or changing any medication.